Related Experiment Video
Updated: Jun 17, 2026
11:57
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
Published on: July 23, 2017
Pancreas vs. islet transplantation: a call on the future
Marina Vardanyan1, Edward Parkin, Christine Gruessner
1Department of Surgery, College of Medicine, University of Arizona, Tucson, Arizona 85724, USA.
Current Opinion in Organ Transplantation
|December 17, 2009
Summary
Pancreas transplantation can reverse type 1 diabetes and its complications, but requires major surgery. Islet cell transplantation is a promising alternative, though further advancements are needed for optimal patient outcomes.
Area of Science:
- Transplantation immunology
- Endocrinology
- Metabolic disease research
Background:
- Type 1 diabetes (T1D) management remains challenging for patients unresponsive to conventional therapies.
- Whole pancreas and islet cell transplantation offer potential curative options for T1D.
- Evaluating the future potential of these advanced therapies is crucial.
Purpose of the Study:
- To review current literature on whole pancreas and islet cell transplantation for T1D.
- To assess the future prospects of these therapies for T1D patients.
- To compare the efficacy and challenges of both transplantation methods.
Main Methods:
- Systematic review of recent reports on pancreas and islet cell transplantation.
- Analysis of clinical outcomes, benefits, and limitations.
- Focus on patient populations with suboptimal response to conventional T1D therapy.
Main Results:
- Pancreas transplantation effectively reverses diabetes and improves complications, considered the gold standard for select T1D patients.
- Requires major surgery and lifelong immunosuppression.
- Islet cell transplantation shows promise but requires significant advancements for reliable therapeutic outcomes.
Conclusions:
- Pancreas transplantation is a well-established, albeit invasive, option for specific T1D patients.
- Islet cell transplantation is an emerging alternative with potential but needs further development.
- Patient-specific factors must guide the choice between pancreas and islet cell transplantation.
